Register Now!

The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, reshaping clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio for our inaugural Digital Health Impact 2019 event, part of Biotech Week Boston, as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for life sciences and digital health innovators to converge and ultimately deliver better outcomes for patients. Contact Laura Rudberg for sponsorship opportunities. View our sponsorship prospectus here

Digital Health Impact 2019 Agenda & Speakers

Keynote: What is Digital Health and Where are We Headed?
John Nosta, #1 Global Influencer in Digital Health, Google Health Advisory Board, Fortune Magazine, NostaLab Think Tank  
Digital health maven John Nosta will dissect and define the emerging convergence of digital health and the life sciences, and its potential for creating better patient outcomes. John’s expertise on the full scope of digital health innovations give him a unique perspective to provide expert commentary on everything from ‘tokenized’ financing instruments for drug development to phone apps that help patients and their families navigate a cancer diagnosis and treatment with the ease of the Waze traffic app. Your preconceptions of digital health and its near-term future in the life sciences will be challenged and changed. 

Possible Talk:
Amitabh Chandra, PhD, Harvard Kennedy School
Harvard Kennedy School health policy professor Amitabh Chandra challenges us to consider what budget and societal trade-offs we are willing to make to see the full potential of the digital health wave in the life sciences and beyond. Our health is our most valuable asset, yet we treat it as a right that few want to pay for. Does that need to change to see the full potential of digital health? 

Panel: How Digital Health is Improving Patient Outcomes
Moderated by Chrissy Farr, CNBC Tech & Health Reporter
2018 witnessed the first FDA-approved prescription-only phone app for treating substance abuse disorder. Wearables and other patient test data are now integrated directly to the physician or to the clinical trial sponsor. This panel will feature a discussion of whether and how digital health is improving patient care, whether it’s reducing costs, and what needs to be done for it to reach its full potential? Featuring Panelists: Grace Colon, PhD, Chairman, ProterixBio, Yuri Maricich, MD, CMO, Pear Therapeutics, Raolat Abdulai, MD, MMSc, Sanofi.

Luncheon keynote:
John Halamka, MD, CIO, Beth Israel Lahey Health
Beth Israel-Lahey Health CIO John Halamka shares the provider perspective, not only as a physician, but as an architect connecting a $6 billion, 4,000 physician and 35,000 employee health system. Distilling the vastness of information to useful actions at the patient/doctor interface is a daunting challenge.

Fireside Chat/Conversation: Becoming a Digital Health Founder 
Tanzeem Choudhury, PhD, HealthRhythms Co-founder & Bill Geary, Investor
Founder Tanzeem Choudhury and investor Bill Geary discuss what it takes to find an important gap in the healthcare continuum, then the long road to learning, pressure-testing, financing and building that idea into a product and company that can make a positive difference to patients. Investors must sift through thousands of ideas and founders are rejected by an equal number of investors before a match arises. This conversation will look at what it really takes to get a digital health company off the ground.

Panel: Turning Data into Action…Is Data the New Oil?
Moderated by Luba Greenwood, J.D., Google - Verily   
Founders and large tech leaders balance the hype with the hope. Hear from those who have succeeded in growing their companies and how they need to collaborate with the big companies to cross the technology chasm to a majority of users from across the healthcare spectrum from biopharma, to providers and payers. Featuring Panelists: Jay DeSai, CEO, Patient Ping, Hans Constandt CEO, Ontoforce & Piali De, CEO, Senscio Systems.

Closing Keynote: Prescriptions and Outcomes
Troyen Brennan, MD, MPD, EVP & CMO, CVS Health
CVS/Aetna Chief physician Troy Brennan brings it all together from filling the prescription to paying for and tracking patients’ health. Integrating the largest pharmacy in the U.S. with the 3rd largest health insurer offers unique and massive data opportunities to save and to better treat. How will patients benefit from this mega-disruptor who is also stepping into the primary care arena?